Jefferies Group’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-772
Closed -$302K 1681
2021
Q1
$302K Sell
772
-6,940
-90% -$3.42M ﹤0.01% 1241
2020
Q4
$4.32M Sell
7,712
-8
-0.1% -$5.07K 0.03% 458
2020
Q3
$5.39M Buy
+7,720
New +$6.02M 0.06% 271
2020
Q1
Sell
-386
Closed -$439K 2084
2019
Q4
$439K Buy
+386
New +$420K ﹤0.01% 1894
2018
Q3
Sell
-795
Closed -$1.62M 2407
2018
Q2
$1.62M Buy
+795
New +$1.81M 0.01% 999
2017
Q3
Sell
-4,439
Closed -$6.04M 2341
2017
Q2
$6.04M Buy
+4,439
New +$5.36M 0.04% 450
2017
Q1
Sell
-5,481
Closed -$4.38M 2328
2016
Q4
$4.38M Sell
5,481
-1,699
-24% -$1.35M 0.02% 618
2016
Q3
$6.3M Buy
7,180
+2,656
+59% +$1.92M 0.03% 454
2016
Q2
$2.54M Buy
+4,524
New +$2.56M 0.01% 769
2015
Q4
Sell
-409
Closed -$453K 2286
2015
Q3
$453K Sell
409
-718
-64% -$1.31M ﹤0.01% 1553
2015
Q2
$2.46M Sell
1,127
-3,629
-76% -$7.39M 0.01% 812
2015
Q1
$7.44M Buy
+4,756
New +$6.28M 0.04% 306

Other funds holding BLUE

Jefferies Group's BLUE Position: Q2 2021 in Review

Jefferies Group sold out of bluebird bio (BLUE) in Q2 2021, closing a stake of 463 shares — an estimated $181K sold.

Jefferies Group first reported a position in BLUE in Q1 2015 and held it in 11 quarters. The position peaked at $2.23M in Q2 2018. 232 funds tracked by Wall St. Rank hold BLUE as of Q2 2021.

  • Jefferies Group reported no remaining bluebird bio position as of Q2 2021 after selling out during the quarter.
  • Jefferies Group sold 463 bluebird bio shares in Q2 2021, an estimated $181K.
  • Jefferies Group first reported a position in bluebird bio in Q1 2015 and held it in 11 quarters.
  • Jefferies Group's bluebird bio position peaked at $2.23M in Q2 2018.
  • 232 funds tracked by Wall St. Rank held bluebird bio as of Q2 2021.

Based on Jefferies Group's 13F filing for Q2 2021, filed 16 Aug 2021.